Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

Men taking valproate advised by MHRA to use effective contraception

The regulator advises that males and their partners should use effective contraception during, and for at least three months after, valproate treatment.…

Martin Sawer: ‘NHS hospitals owe wholesalers millions of pounds in overdue invoices’

Here, Martin Sawer, executive director of the Healthcare Distribution Association, explains how wholesalers are part of the ‘critical infrastructure’ of UK healthcare, but the industry faces several challenges.…

Chair of RPS English Pharmacy Board appointed to NHS Assembly

The NHS Assembly was formed in 2019 to shape the delivery of the ‘NHS long-term plan’.…

One-third of adult social care providers say medicines support from community pharmacy has improved over past year

Respondents to the Care Quality Commission survey said they typically received advice from community pharmacy on medicines side effects, over-the-counter medicine and safe medicines administration.…

NICE recommends emergency kits for people with adrenal insufficiency to cut hospital admissions

The new guidance says healthcare providers should consider providing eligible patients with two or three emergency adrenal insufficiency kits.…

What will it take to fix pharmacy’s stubbornly unchanged ethnicity pay gap?

The Pharmaceutical Journal’s latest survey data show ethnic minority pharmacists continue to be paid less than their white colleagues.…

Psilocybin may be as effective as escitalopram in treating depression, study suggests

A meta-analysis has found similar effectiveness of psilocybin compared with escitalopram in the treatment of depression, but the study does have limitations.…

Alzheimer’s treatment lecanemab too costly for NHS, says NICE draft guidance

The National Institute for Health and Care Excellence has determined that the small benefit that lecanemab provides patients in the early stages of Alzheimer’s disease does not justify the cost to the NHS.…

Deaths related to drug misuse in Scotland rose by almost 12% in 2023

The National Records of Scotland data show that opioids were implicated in 80% of the misuse-related deaths in 2023.…

Registration assessment will be held online until at least 2029, says GPhC

The regulator said it was undertaking a procurement process “to provide certainty in relation to delivering the registration assessment” while it considers its future.…